{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:37:05Z","timestamp":1790469425632,"version":"4.1.0"},"reference-count":143,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>There is a growing number of perinatally HIV-1-infected children worldwide who must maintain life-long ART. In early life, HIV-1 infection is established in an immunologically inexperienced environment in which maternal ART and immune dynamics during pregnancy play a role in reservoir establishment. Children that initiated early antiretroviral therapy (ART) and maintained long-term suppression of viremia have smaller and less diverse HIV reservoirs than adults, although their proviral landscape during ART is reported to be similar to that of adults. The ability of these early infected cells to persist long-term through clonal expansion poses a major barrier to finding a cure. Furthermore, the effects of life-long HIV persistence and ART are yet to be understood, but growing evidence suggests that these individuals are at an increased risk for developing non-AIDS-related comorbidities, which underscores the need for an HIV cure.<\/jats:p>","DOI":"10.3390\/v13061134","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T22:26:01Z","timestamp":1623709561000},"page":"1134","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["HIV-1 Persistence in Children during Suppressive ART"],"prefix":"10.3390","volume":"13","author":[{"given":"Mary Grace","family":"Katusiime","sequence":"first","affiliation":[{"name":"HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert U.","family":"Van Zyl","sequence":"additional","affiliation":[{"name":"Division of Medical Virology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town 8000, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Cotton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Tygerberg Children\u2019s Hospital and Family Center for Research with Ubuntu, Stellenbosch University, Cape Town 7505, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Kearney","sequence":"additional","affiliation":[{"name":"HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"key":"ref_1","unstructured":"UNAIDS (2020). Global HIV & AIDS Statistics\u20132020 Fact Sheet, UNAIDS."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Myer, L., Essajee, S., Broyles, L.N., Watts, D.H., Lesosky, M., El-Sadr, W.M., and Abrams, E.J. (2017). Pregnant and breastfeeding women: A priority population for HIV viral load monitoring. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002375"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1746-4358-5-10","article-title":"Breastfeeding and HIV: Experiences from a decade of prevention of postnatal HIV transmission in sub-Saharan Africa","volume":"5","author":"Moland","year":"2010","journal-title":"Int. Breastfeed. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijid.2020.06.081","article-title":"Horizontal HIV transmission to children of HIV-uninfected mothers: A case series and review of the global literature","volume":"98","author":"Myburgh","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/AOG.0000000000001929","article-title":"Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus","volume":"129","author":"Scott","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_6","unstructured":"WHO (2021, February 02). Global Health Sector Strategy on HIV 2016\u20132021 towards Ending AIDS. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246178\/WHO-HIV-2016.05-eng.pdf?sequence=1."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","article-title":"Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: Results from multiple mathematical models","volume":"7","author":"Jewell","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10461-018-2235-x","article-title":"Paediatric ART Adherence in South Africa: A comprehensive analysis","volume":"23","author":"Peters","year":"2019","journal-title":"AIDS Behav."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.puhe.2017.12.010","article-title":"Factors impacting antiretroviral therapy adherence among human immunodeficiency virus\u2013positive adolescents in Sub-Saharan Africa: A systematic review","volume":"157","author":"Ammon","year":"2018","journal-title":"Public Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/dc10-0633","article-title":"Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy","volume":"33","author":"Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/EDE.0000000000000815","article-title":"Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: A systematic review and meta-analysis","volume":"29","author":"Nansseu","year":"2018","journal-title":"Epidemiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/COH.0000000000000406","article-title":"Hypertension in people living with HIV","volume":"12","author":"Reiss","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/jch.14088","article-title":"Duration of antiretroviral therapy among people living with HIV and incidence of hypertension in Ghana","volume":"22","author":"Sarfo","year":"2020","journal-title":"J. Clin. Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dimala, C.A., Blencowe, H., and Choukem, S.P. (2018). The association between antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: A systematic review and meta-analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201404"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sabin, C.A. (2013). Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-251"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/86531","article-title":"Generation of HIV latency during thymopoiesis","volume":"7","author":"Brooks","year":"2001","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a007096","DOI":"10.1101\/cshperspect.a007096","article-title":"HIV Latency","volume":"1","author":"Siliciano","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis","volume":"364","author":"Newell","year":"2004","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mjafi.2013.08.005","article-title":"Rate of decline in CD4 count in HIV patients not on antiretroviral therapy","volume":"70","author":"Patrikar","year":"2014","journal-title":"Med. J. Armed Forces India"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM199705083361901","article-title":"Viral load and disease progression in infants infected with human immunodeficiency virus type","volume":"336","author":"Shearer","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1203\/00006450-199708000-00018","article-title":"Cytokine production differs in children and adults","volume":"42","author":"Lilic","year":"1997","journal-title":"Pediatr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(15)00087-0","article-title":"Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: A retrospective analysis","volume":"15","author":"Payne","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_25","first-page":"229","article-title":"Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers","volume":"11","author":"Shalekoff","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/088922204322996545","article-title":"Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents","volume":"20","author":"Tuttle","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: The pediatric aids clinical trials group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-3083.2012.02671.x","article-title":"Paediatric reference values for the peripheral T cell compartment","volume":"75","author":"Gemen","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.it.2009.04.003","article-title":"Thymic involution and immune reconstitution","volume":"30","author":"Lynch","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.aids.0000216366.46195.81","article-title":"Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy","volume":"20","author":"Lee","year":"2006","journal-title":"AIDS"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2249.2000.01152.x","article-title":"CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients","volume":"119","author":"Franco","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Eriksson, S., Graf, E.H., Dahl, V., Strain, M.C., Yukl, S.A., Lysenko, E.S., Bosch, R.J., Lai, J., Chioma, S., and Emad, F. (2013). Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003174"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1128\/JVI.00553-16","article-title":"Establishment and reversal of HIV-1 latency in naive and central memory CD4+T cells in vitro","volume":"90","author":"Zerbato","year":"2016","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/cid\/ciz108","article-title":"Naive CD4+ T cells harbor a large inducible reservoir of latent, replication-competent human immunodeficiency virus type","volume":"69","author":"Zerbato","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/cid\/ciz378","article-title":"Genetic evidence that naive T cells can contribute significantly to the human immunodeficiency virus intact reservoir: Time to re-evaluate their role","volume":"69","author":"Rullo","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu297","article-title":"HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment","volume":"210","author":"Luzuriaga","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/QAD.0000000000001739","article-title":"Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge","volume":"32","author":"Veldsman","year":"2018","journal-title":"AIDS (Lond. Engl.)"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-10884-9","article-title":"Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART","volume":"10","author":"Bachmann","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hill, A.L., Rosenbloom, D.I.S., Goldstein, E., Hanhauser, E., Kuritzkes, D.R., Siliciano, R.F., and Henrich, T.J. (2016). Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV. PLoS Pathog., 12.","DOI":"10.1101\/038091"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00002030-200401020-00012","article-title":"Maternal viral load and rate of disease progression among vertically HIV-1-infected children: An international meta-analysis","volume":"18","author":"Ioannidis","year":"2004","journal-title":"AIDS"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00002030-200304110-00012","article-title":"Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children","volume":"17","author":"Abrams","year":"2003","journal-title":"AIDS"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAI.0b013e31819c16d8","article-title":"Pediatric HIV-1 in Kenya: Pattern and correlates of viral load and association with mortality","volume":"51","author":"Obimbo","year":"2009","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1128\/JVI.00197-11","article-title":"The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population","volume":"85","author":"Russell","year":"2011","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission","volume":"303","author":"Derdeyn","year":"2004","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1742-4690-8-67","article-title":"Genotypic and functional properties of early infant HIV-1 envelopes","volume":"8","author":"Kishko","year":"2011","journal-title":"Retrovirology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kumar, A., Smith, C.E.P., Giorgi, E.E., Eudailey, J., Martinez, D.R., Yusim, K., Douglas, A.O., Stamper, L., McGuire, E., and Labranche, C.C. (2018). Infant transmitted\/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006944"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e00176-20","DOI":"10.1128\/mBio.00176-20","article-title":"Maternal broadly neutralizing antibodies can select for neutralization-resistant, infant-transmitted\/founder HIV variants","volume":"11","author":"Martinez","year":"2020","journal-title":"mBio"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/JVI.80.2.835-844.2006","article-title":"Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/QAD.0000000000000178","article-title":"Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children","volume":"28","author":"Ananworanich","year":"2014","journal-title":"AIDS"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/INF.0b013e318290622e","article-title":"Birth diagnosis of HIV infection in infants to reduce infant mortality and monitor for elimination of mother-to-child transmission","volume":"32","author":"Lilian","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(13)61409-9","article-title":"Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: Results from the children with HIV early antiretroviral (CHER) randomised trial","volume":"382","author":"Cotton","year":"2013","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/infdis\/jiu827","article-title":"Early antiretroviral therapy in South African children reduces HIV-1-infected cells and cell-associated HIV-1 RNA in blood mononuclear cells","volume":"212","author":"Bedison","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"De Oliveira, M.F., Gianella, S., Letendre, S., Scheffler, K., Pond, S.L.K., Smith, D.M., Strain, M., and Ellis, R.J. (2015). Comparative analysis of cell-associated HIV DNA levels in cerebrospinal fluid and peripheral blood by droplet digital PCR. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139510"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jviromet.2012.08.019","article-title":"Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR","volume":"186","author":"Henrich","year":"2012","journal-title":"J. Virol. Methods"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kiselinova, M., Pasternak, A., De Spiegelaere, W., Vogelaers, D., Berkhout, B., and Vandekerckhove, L. (2014). Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-associated HIV-1 RNA. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085999"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Strain, M.C., Lada, S.M., Luong, T., Rought, S.E., Gianella, S., Terry, V.H., Spina, C.A., Woelk, C.H., and Richman, D.D. (2013). Highly precise measurement of HIV DNA by droplet digital PCR. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055943"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1120248109","article-title":"Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection","volume":"109","author":"Archin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/cid\/civ456","article-title":"Establishment and replenishment of the viral reservoir in perinatally HIV-1-infected children initiating very early antiretroviral therapy","volume":"61","author":"Puertas","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/QAD.0000000000001565","article-title":"Early antiretroviral therapy reduces HIV DNA following perinatal HIV infection","volume":"31","author":"Foster","year":"2017","journal-title":"AIDS"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1172\/JCI94582","article-title":"No evidence of HIV replication in children on antiretroviral therapy","volume":"127","author":"Katusiime","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamapediatrics.2014.1560","article-title":"Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents","volume":"168","author":"Persaud","year":"2014","journal-title":"JAMA Pediatr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-med-091114-111159","article-title":"Early combination antiretroviral therapy limits HIV-1 persistence in children","volume":"67","author":"Luzuriaga","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kuhn, L., Paximadis, M., Da Costa Dias, B., Loubser, S., Strehlau, R., Patel, F., Shiau, S., Coovadia, A., Abrams, E.J., and Tiemessen, C.T. (2018). Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195514"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/QAI.0000000000001789","article-title":"Early and highly suppressive antiretroviral therapy are main factors associated with low viral reservoir in European perinatally HIV-infected children","volume":"79","author":"Tagarro","year":"2018","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ajibola, G., Garcia-Broncano, P., Maswabi, K., Bennett, K., Hughes, M.D., Moyo, S., Mohammed, T., Jean-Philippe, P., Sakoi, M., and Batlang, O. (2021). Viral reservoir in early-treated HIV-infected children and markers for sustained viral suppression. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciab143"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Massanella, M., Puthanakit, T., Leyre, L., Jupimai, T., Sawangsinth, P., De Souza, M., Suntarattiwong, P., Kosalarksa, P., Borkird, T., and Kanjanavanit, S. (2020). Continuous prophylactic antiretrovirals\/antiretroviral therapy since birth reduces seeding and persistence of the viral reservoir in children vertically infected with human immunodeficiency virus. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciaa718"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"McManus, M., Mick, E., Hudson, R., Mofenson, L.M., Sullivan, J.L., Somasundaran, M., and Luzuriaga, K. (2016). PACTG 356 investigators early combination antiretroviral therapy limits exposure to HIV-1 replication and cell-associated HIV-1 DNA levels in infants. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154391"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/QAD.0b013e3283553638","article-title":"Dynamics of the resting CD4+ T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age","volume":"26","author":"Persaud","year":"2012","journal-title":"AIDS"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"003","DOI":"10.1385\/1-59259-907-9:003","article-title":"Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals","volume":"304","author":"Siliciano","year":"2005","journal-title":"Hum. Retrovir. Protoc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"ofv123","DOI":"10.1093\/ofid\/ofv123","article-title":"Designing and interpreting limiting dilution assays: General principles and applications to the latent reservoir for human immunodeficiency virus-1","volume":"2","author":"Rosenbloom","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"ref_73","first-page":"120","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_74","first-page":"183","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nat. Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Rainwater-Lovett, K., Ziemniak, C., Watson, D., Luzuriaga, K., Siberry, G., Petru, A., Chen, Y., Uprety, P., McManus, M., and Ho, Y.-C. (2017). Paucity of intact non-induced provirus with early, long-term antiretroviral therapy of perinatal HIV infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170548"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e134105","DOI":"10.1172\/jci.insight.134105","article-title":"Differences in inducibility of the latent HIV reservoir in perinatal and adult infection","volume":"5","author":"Dhummakupt","year":"2020","journal-title":"JCI Insight"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1073\/pnas.1406663111","article-title":"Predicting the outcomes of treatment to eradicate the latent reservoir for HIV","volume":"111","author":"Hill","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","article-title":"Absence of detectable HIV-1 viremia after treatment cessation in an infant","volume":"369","author":"Persaud","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMc1413931","article-title":"Viremic relapse after HIV-1 remission in a perinatally infected child","volume":"372","author":"Luzuriaga","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2352-3018(15)00232-5","article-title":"HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: A case report","volume":"3","author":"Frange","year":"2016","journal-title":"Lancet HIV"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41467-019-08311-0","article-title":"A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation","volume":"10","author":"Violari","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","article-title":"Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection","volume":"24","author":"Colby","year":"2018","journal-title":"Nat. Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"S\u00e1ez-Ciri\u00f3n, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., and Prazuck, T. (2013). Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003211"},{"key":"ref_86","unstructured":"Trautmann, L. (2021, January 6\u201310). How to generate good killers by initiating ART (not too) early?. Proceedings of the Conference on Retroviruses and Oppourtunisitc Infections, Virtual, Available online: https:\/\/www.croiconference.org\/abstract\/how-to-generate-good-killers-by-initiating-art-not-too-early\/."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/JVI.01985-12","article-title":"An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells","volume":"87","author":"Wagner","year":"2012","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ympev.2011.11.019","article-title":"The evolution of HIV: Inferences using phylogenetics","volume":"62","author":"Burton","year":"2012","journal-title":"Mol. Phylogenetics Evol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1310\/hct1105-312","article-title":"A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen","volume":"11","author":"Hammer","year":"2010","journal-title":"HIV Clin. Trials"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.2006.0175","article-title":"Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy","volume":"23","author":"Persaud","year":"2007","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_91","first-page":"1","article-title":"HIV evolution and diversity in ART-treated patients","volume":"15","author":"Bale","year":"2018","journal-title":"Retrovirology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.4049\/jimmunol.175.10.6976","article-title":"HIV-1-specific CD8+T cell responses and viral evolution in women and infants","volume":"175","author":"Nie","year":"2005","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JVI.02139-15","article-title":"Origin of rebound plasma HIV includes cells with identical proviruses that are transcriptionally active before stopping of antiretroviral therapy","volume":"90","author":"Kearney","year":"2016","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Kearney, M.F., Spindler, J., Shao, W., Yu, S., Anderson, E.M., O\u2019Shea, A., Rehm, C., Poethke, C., Kovacs, N., and Mellors, J.W. (2014). Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004010"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e25368","DOI":"10.1002\/jia2.25368","article-title":"HIV-1DNA decay is faster in children who initiate ART shortly after birth than later","volume":"22","author":"Veldsman","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/cid\/civ688","article-title":"Cell-associated HIV-1 DNA and RNA decay dynamics during early combination antiretroviral therapy in HIV-1-infected infants","volume":"61","author":"Uprety","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ebiom.2016.07.024","article-title":"HIV DNA set point is rapidly established in acute HIV infection and dramatically reduced by early ART","volume":"11","author":"Ananworanich","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu585","article-title":"HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy","volume":"59","author":"Besson","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1128\/JVI.01046-14","article-title":"Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells","volume":"88","author":"Buzon","year":"2014","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1742-4690-5-107","article-title":"Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy","volume":"5","author":"Fischer","year":"2008","journal-title":"Retrovirology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: Implications for eradication strategies","volume":"212","author":"Crooks","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1172\/JCI135953","article-title":"Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy","volume":"130","author":"Antar","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Peluso, M.J., Bacchetti, P., Ritter, K.D., Beg, S., Lai, J., Martin, J.N., Hunt, P.W., Henrich, T.J., Siliciano, J.D., and Siliciano, R.F. (2020). Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. JCI Insight, 5.","DOI":"10.1172\/jci.insight.132997"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"eaax7350","DOI":"10.1126\/scitranslmed.aax7350","article-title":"Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile","volume":"11","author":"Maddali","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"16948","DOI":"10.1016\/S0021-9258(19)84799-3","article-title":"Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase","volume":"264","author":"Bebenek","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.79.3.1975-1980.2005","article-title":"A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo","volume":"79","author":"Kieffer","year":"2005","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jvi.71.3.2233-2240.1997","article-title":"Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals","volume":"71","author":"Sanchez","year":"1997","journal-title":"J. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"18692","DOI":"10.1073\/pnas.2006816117","article-title":"Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA","volume":"117","author":"Simonetti","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e01519-19","DOI":"10.1128\/JVI.01519-19","article-title":"Intact HIV proviruses persist in children seven to nine years after initiation of antiretroviral therapy in the first year of life","volume":"94","author":"Katusiime","year":"2020","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1128\/JVI.00284-11","article-title":"Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells","volume":"85","author":"Anderson","year":"2011","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.00591-06","article-title":"Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells","volume":"80","author":"Bailey","year":"2006","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Evering, T.H., Mehandru, S., Racz, P., Tenner-Racz, K., Poles, M., Figueroa, A., Mohri, H., and Markowitz, M. (2012). Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002506"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Bull, M., Learn, G., Genowati, I., McKernan, J., Hitti, J., Lockhart, D., Tapia, K., Holte, S., Dragavon, J., and Coombs, R. (2009). Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007122"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"25891","DOI":"10.1073\/pnas.1910334116","article-title":"Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors","volume":"116","author":"Patro","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.1522675113","article-title":"Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo","volume":"113","author":"Simonetti","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"Einkauf","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Research Support, N.I.H.; Extramural Research Support, Non-U.S. Gov\u2019t","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Bui, J.K., Sobolewski, M.D., Keele, B.F., Spindler, J., Musick, A., Wiegand, A., Luke, B.T., Shao, W., Hughes, S.H., and Coffin, J.M. (2017). Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006283"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1172\/JCI138099","article-title":"HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus","volume":"130","author":"Halvas","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"E7908","DOI":"10.1073\/pnas.1617789113","article-title":"Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA","volume":"113","author":"Lorenzi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cell.2015.01.020","article-title":"HIV-1 integration landscape during latent and active infection","volume":"160","author":"Cohn","year":"2015","journal-title":"Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1073\/pnas.1600097113","article-title":"Reservoir expansion by T-cell proliferation may be another barrier to curing HIV infection","volume":"113","author":"Kim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Pinzone, M.R., VanBelzen, D.J., Weissman, S., Bertuccio, M.P., Cannon, L., Hwang, W.-T., Sherman, B., and O\u2019Doherty, U. (2018). Proviral sequencing suggests the majority of the HIV reservoir is expressed over time but significant decay is obscured by clonal expansion. bioRxiv, 348409.","DOI":"10.1101\/348409"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e00568-21","DOI":"10.1128\/mBio.00568-21","article-title":"Early emergence and long-term persistence of HIV-infected T-cell clones in children","volume":"12","author":"Bale","year":"2021","journal-title":"mBio"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e128432","DOI":"10.1172\/jci.insight.128432","article-title":"Clones of infected cells arise early in HIV-infected individuals","volume":"4","author":"Coffin","year":"2019","journal-title":"JCI Insight"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Boshier, F.A.T., Reeves, D.B., Duke, E.R., Swan, D.A., Prlic, M., Cardozo-Ojeda, E.F., and Schiffer, J.T. (2020). Blind uneven proliferation of CD4+ T cells during primary infection generates the majority of the HIV reservoir. medRxiv.","DOI":"10.1101\/2020.04.06.20053231"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00609-1","article-title":"HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells","volume":"8","author":"Cesana","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1086\/510915","article-title":"Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy","volume":"195","author":"Ikeda","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_132","first-page":"E2575","article-title":"Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Simonetti, F.R., Zhang, H., Soroosh, G.P., Duan, J., Rhodehouse, K., Hill, A.L., Beg, S.A., McCormick, K., Raymond, H.E., and Nobles, C.L. (2021). Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo. J. Clin. Investig., 131.","DOI":"10.1172\/JCI145254"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Mendoza, P., Jackson, J.R., Oliveira, T.Y., Gaebler, C., Ramos, V., Caskey, M., Jankovic, M., Nussenzweig, M.C., and Cohn, L.B. (2020). Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir. J. Exp. Med., 217.","DOI":"10.1084\/jem.20200051"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1128\/JVI.00052-07","article-title":"Cytomegalovirus infection in gambian infants leads to profound CD8 T-cell differentiation","volume":"81","author":"Miles","year":"2007","journal-title":"J. Virol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cid\/ciy961","article-title":"Unexpectedly high prevalence of cytomegalovirus DNA emia in older children and adolescents with perinatally acquired human immunodeficiency virus infection","volume":"69","author":"Yindom","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1200\/JCO.2015.60.8448","article-title":"Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at memorial sloan kettering cancer center","volume":"33","author":"Horvat","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"805151","DOI":"10.1155\/2012\/805151","article-title":"Suboptimal immune reconstitution in vertically HIV infected children: A view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment","volume":"2012","author":"Cotugno","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1097\/QAD.0b013e3280113f29","article-title":"Varicella vaccination in HIV-1-infected children after immune reconstitution","volume":"20","author":"Bekker","year":"2006","journal-title":"AIDS"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e91963","DOI":"10.1172\/jci.insight.91963","article-title":"BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial","volume":"2","author":"Gasper","year":"2017","journal-title":"JCI Insight"},{"key":"ref_141","first-page":"88","article-title":"BCG vaccination in South African HIV-exposed infants\u2014Risks and benefits","volume":"99","author":"Hesseling","year":"2009","journal-title":"S. Afr. Med. J."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/QAD.0000000000002275","article-title":"HIV-mediated immune aging in young adults infected perinatally or during childhood","volume":"33","author":"Fastenackels","year":"2019","journal-title":"AIDS"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/QAD.0000000000002328","article-title":"Profound immune consequences for young adults infected with HIV perinatally or during childhood: A cautionary tale regarding adherence to antiretroviral therapy","volume":"33","author":"Williams","year":"2019","journal-title":"AIDS"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/6\/1134\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:13:43Z","timestamp":1760163223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/6\/1134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":143,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["v13061134"],"URL":"https:\/\/doi.org\/10.3390\/v13061134","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,12]]}}}